ライフサイエンスコーパス: neonatal death

1 the genetic basis of severe microcephaly and neonatal death.

2 defined as the combination of stillbirth and neonatal death.

3 estational age, miscarriage, stillbirth, and neonatal death.

4 rative skin conditions and for stillbirth or neonatal death.

5 oxygen supplementation necessary to prevent neonatal death.

6 s in altered epithelial cell homeostasis and neonatal death.

7 ultiorgan pathologies, vascular defects, and neonatal death.

8 cases of pSBI diagnosed for each associated neonatal death.

9 Cs results in severe mid-facial clefting and neonatal death.

10 a CI subunit, cause severe CI deficiency and neonatal death.

11 severe microcephaly, small somatic size, and neonatal death.

12 y impaired inspiratory rhythm and pronounced neonatal death.

13 a is associated with increased risk of early neonatal death.

14 rity are amongst the strongest predictors of neonatal death.

15 ion, 0.252-0.552) were the leading causes of neonatal death.

16 D die as a TOFPA, late fetal death, or early neonatal death.

17 lting in incomplete villus morphogenesis and neonatal death.

18 ated with an increased risk of stillbirth or neonatal death.

19 nd lens degeneration, brain hemorrhages, and neonatal death.

20 racic cavity, leading to lung hypoplasia and neonatal death.

21 , hindbrain, and inner ear deficiencies, and neonatal death.

22 demia, which is sufficiently severe to cause neonatal death.

23 ported that homozygous (MTPa-/-) mice suffer neonatal death.

24 and its ablation results in exencephaly and neonatal death.

25 ng of some breeding pairs, renal failure and neonatal death.

26 with recurrent spontaneous abortion or early neonatal death.

27 th multiple malformations resulting in early neonatal death.

28 r maternal death experienced a stillbirth or neonatal death.

29 weight for gestational age), stillbirth, and neonatal death.

30 reterm birth, low birth weight, and fetal or neonatal death.

31 k for preterm birth, very preterm birth, and neonatal death.

32 eath attributed to underlying disease and no neonatal deaths.

33 There were no neonatal deaths.

34 s, blindness, encephalitis, and occasionally neonatal deaths.

35 re a leading cause of the 2.9 million annual neonatal deaths.

36 lth surveys for information on the timing of neonatal deaths.

37 83% of all maternal deaths, stillbirths, and neonatal deaths.

38 l abnormalities, seven stillbirths, and nine neonatal deaths.

39 munity care at 90% coverage averts 18-37% of neonatal deaths.

40 uld provide a cost-effective way of reducing neonatal deaths.

41 undergoing a trial of labor), including two neonatal deaths.

42 tion, and a small group of causes leading to neonatal deaths.

43 l livebirths, stillbirths, miscarriages, and neonatal deaths.

44 tributing underlying and immediate causes of neonatal deaths.

45 infections as the leading immediate cause of neonatal deaths.

46 We observed 203 fetal losses and 20 neonatal deaths.

47 w birth weight (0.68; .29-1.57) and fetal or neonatal death (0.24; .04-1.52).

48 1.4%), intrauterine fetal demise (2.8%), and neonatal death (1.4%).

49 tal interventions by 2025 could avert 71% of neonatal deaths (1.9 million [range 1.6-2.1 million]), 3

50 1.00-1.35; I2 = 93.7%; n = 11 studies); for neonatal death, 1.15 (95% CI, 1.07-1.23; I2 = 78.5%; n =

51 y between groups (six [2.0%] vs three [1.0%] neonatal deaths; 1.0, -1.04 to 2.97; p=0.322).

52 We enrolled 153 neonatal deaths, 106 aged 3-28 days.

53 5% confidence interval (CI): 1.23, 4.17) for neonatal death, 2.44 (95% CI: 1.76, 3.37) for respirator

54 on deaths in 2010, consisting of 3.1 million neonatal deaths, 2.3 million postneonatal deaths, and 2.

55 (95% CI, 67-81), and 86 (95% CI, 76-98); for neonatal death, 20, 21 (95% CI, 19-23), and 24 (95% CI,

56 d RR of 359.4 (95% CI 277.3-465.9) for early neonatal death, 30.5 (18.0-51.6) for late neonatal death

57 0 early fetal deaths and stillbirths, 62 000 neonatal deaths, 44 000 preterm or low weight births, an

58 te outcome (105/408 [26%] vs 115/419 [27%]), neonatal death (47/449 [11%] vs 58/449 [13%]), severe IV

59 Thus, 67 000 maternal deaths, 440 000 neonatal deaths, 473 000 child deaths, and 564 000 still

60 participants; OR, 0.43; 95% CI, 0.19-0.99), neonatal death (5 studies, 374 participants; OR, 0.26; 9

61 ths (total about 290,000) and stillbirths or neonatal deaths (5.5 million) occur every year.

62 In eight of the 13 countries with the most neonatal deaths (55% worldwide), we undertook a systemat

63 In a Scotland-wide study of neonatal deaths, 70 brains have been examined.

64 CNS-specific knockout of Ufm1 in mice causes neonatal death accompanied by microcephaly and apoptosis

65 In 2013, neonatal deaths accounted for 41.6% of under-5 deaths co

66 tio [OR], 1.17; 95% CI, 0.96-1.41; P = .12), neonatal death (adjusted OR, 1.23; 95% CI, 0.96-1.57; P

67 ity was associated with an increased odds of neonatal death after adjustment for confounding factors

68 During the same period, the OR for neonatal death after preeclamptic pregnancy remained rel

69 between maternal arsenic exposure and fetal/neonatal death (all mortality between enrollment and 1 m

70 Every year about 70% of neonatal deaths (almost 3 million) happen because effect

71 one resulted in significantly lower risks of neonatal death alone and stillbirth or neonatal death th

72 , and possible maternal bacterial infection; neonatal death alone and stillbirth or neonatal death we

73 The primary outcomes were neonatal death alone, stillbirth or neonatal death, and

74 l age, very low birthweight, miscarriage, or neonatal death, although few data were available for the

75 lestasis (due to Abcb11 deficiency) produces neonatal death among all offspring within 24 h of birth

76 no reports of maternal death, stillbirth, or neonatal death among the donors.

77 Study (CCSS), of the risk of stillbirth and neonatal death among the offspring of men and women who

78 was a composite of intrapartum fetal death, neonatal death, an Apgar score of 3 or less at 5 minutes

79 Raf deletion caused neonatal death and a significant expansion of the hypert

80 ks), we estimated adjusted relative risks of neonatal death and absolute rate differences in neonatal

81 B Streptococcus (GBS), is a leading cause of neonatal death and an emerging pathogen in adults.

82 The primary outcome was the composite of neonatal death and any of several adverse events, includ

83 ere associated with higher relative risks of neonatal death and greater absolute rate differences in

84 face-mask ventilation with respect to early neonatal death and moderate-to-severe hypoxic-ischemic e

85 neonatal hypoxia-ischemia, a major cause of neonatal death and pediatric disability.

86 ary neonatal composite outcome that included neonatal death and serious neonatal complications (14.3%

87 care for patients experiencing miscarriage, neonatal death and stillbirth as part of their work.

88 Sub-Saharan Africa had the highest risk of neonatal death and, therefore, had the highest risk of d

89 and there were 36,485 infant deaths (25,110 neonatal deaths and 11,375 postneonatal deaths).

90 A quarter of the world's neonatal deaths and 15% of maternal deaths happen in Ind

91 Of the 3.7 million neonatal deaths and 3.3 million stillbirths each year, 9

92 ies do not get a birth certificate, and most neonatal deaths and almost all stillbirths have no death

93 However, less than 5% of neonatal deaths and even fewer stillbirths have death re

94 the biggest risk factor for more than 80% of neonatal deaths and increases risk of post-neonatal mort

95 tillbirth), and the secondary endpoints were neonatal deaths and malformations.

96 al homoplasmic mutation that resulted in six neonatal deaths and one surviving child with Leigh syndr

97 Progress in reducing maternal and neonatal deaths and stillbirths is impeded by data gaps,

98 impact of midwives on reducing maternal and neonatal deaths and stillbirths under several interventi

99 he vast majority of the world's maternal and neonatal deaths and stillbirths.

100 o meet Every Newborn targets of ten or fewer neonatal deaths and ten or fewer stillbirths per 1000 bi

101 nd pneumonia were not accelerated, causes of neonatal deaths and undernutrition were not addressed, a

102 Safety outcomes were deaths in utero and neonatal deaths and were assessed in all randomly alloca

103 wth restriction, which increases the risk of neonatal deaths and, for survivors, of stunting by 2 yea

104 ly neonatal death, 30.5 (18.0-51.6) for late neonatal death, and 50.2 (42.8-59.0) for infant death.

105 ted mothers on the end points of stillbirth, neonatal death, and congenital syphilis were obtained fr

106 onal-age infants, preterm birth, stillbirth, neonatal death, and major congenital malformations.

107 The risks of stillbirth, neonatal death, and perinatal death increased with the a

108 t smoking increases the risks of stillbirth, neonatal death, and perinatal death.

109 mes were neonatal death alone, stillbirth or neonatal death, and possible maternal bacterial infectio

110 complications in labour carry a high risk of neonatal death, and poverty is strongly associated with

111 emia, respiratory distress, low Apgar score, neonatal death, and stillbirth.

112 In mice, the absence of Gas2l2 caused neonatal death, and the conditional deletion of Gas2l2 i

113 ernal deaths, 849 000 stillbirths, 1 498 000 neonatal deaths, and 1 515 000 additional child deaths.

114 s could avert 22% of maternal deaths, 23% of neonatal deaths, and 14% of stillbirths, equating to 1.3

115 decrease in maternal deaths, 28% decrease in neonatal deaths, and 22% fewer stillbirths compared to a

116 s could avert 41% of maternal deaths, 39% of neonatal deaths, and 26% of stillbirths, equating to 2.2

117 912 (98%) of 933 cases (180 stillbirths, 449 neonatal deaths, and 304 child deaths); two or more cond

118 ths, more than 4311 perinatal deaths, 11,294 neonatal deaths, and 4983 infant deaths were included.

119 of half a million maternal deaths, 4 million neonatal deaths, and 6 million child deaths.

120 s would avert 67% of maternal deaths, 64% of neonatal deaths, and 65% of stillbirths, allowing 4.3 mi

121 d immediate causes of death for stillbirths, neonatal deaths, and child (age 1-59 months) deaths.

122 um stillbirths, end preventable maternal and neonatal deaths, and improve child development.

123 We identified births, stillbirths, and neonatal deaths, and interviewed mothers 6 weeks after d

124 t encompassed eclampsia, preeclampsia, fetal/neonatal deaths, and small litter sizes occurred in some

125 risk of stillbirth, very preterm birth, and neonatal death; and ZDV-3TC-LPV-R was associated with hi

126 s in the study, 6054 were stillbirths; 3609, neonatal deaths; and 1578, postneonatal deaths.

127 aths, 531,000 stillbirths, and 1.325 million neonatal deaths annually by 2020 at an estimated running

128 ternal undernutrition contributes to 800,000 neonatal deaths annually through small for gestational a

129 many as 163 513 maternal deaths and 803 129 neonatal deaths annually.

130 revalence rate ratio [aPRR] 1.19, P = .8) or neonatal death (aPRR 0.68, P = .6).

131 Globally, the main direct causes of neonatal death are estimated to be preterm birth (28%),

132 ncluding the east African region, a third of neonatal deaths are due to infections.

133 Reducing maternal and neonatal deaths are important global health priorities.

134 The highest numbers of neonatal deaths are in south-central Asian countries and

135 Early neonatal deaths are sometimes under-reported or might be

136 Almost all (99%) neonatal deaths arise in low-income and middle-income co

137 ount for a quarter of the 2.8 million annual neonatal deaths, as well as approximately 3% of all disa

138 ha and beta) in murine podocytes causes late neonatal death associated with massive albuminuria and r

139 ic conditions, whereas the relative risk for neonatal death associated with maternal affective disord

140 on 2 families with a history of in utero and neonatal deaths associated with nonimmune hydrops fetali

141 ere 0.68 million (0.46 million-0.92 million) neonatal deaths associated with pSBI in 2012.

142 -two infants were born prematurely; with one neonatal death at 6 weeks.

143 gnificantly increased risk of stillbirth and neonatal death at doses greater than 10.00 Gy (five [18%

144 view to quantify the risks of stillbirth and neonatal death at term (from 37 weeks gestation) accordi

145 spective, observational pilot study enrolled neonatal deaths at Chris Hani Baragwanath Academic Hospi

146 resulting in a decrease in the percentage of neonatal death attributable to SGA.

147 APOs included fetal or neonatal death; birth before 36 weeks due to placental i

148 r and pancreatic beta cells are rescued from neonatal death, but develop lipoatrophic diabetes and di

149 Boys have a higher biological risk of neonatal death, but girls often have a higher social ris

150 newborns against preterm delivery and early neonatal death, but the impact beyond the neonatal perio

151 to reduce maternal deaths, stillbirths, and neonatal deaths by 2025 in all countries tested.

152 by 2030, we project 22.7 million cumulative neonatal deaths by 2030.

153 rage of essential interventions would reduce neonatal deaths by an estimated 71%, benefit women and c

154 es that provided estimates of stillbirths or neonatal deaths by gestation week.

155 nnual number of stillbirths by up to 64,000, neonatal deaths by up to 25,000, and annual incidence of

156 l age had just three times the likelihood of neonatal death compared to babies born term, (OR 3.2 [95

157 mpact of universal screening on stillbirths, neonatal deaths, congenital syphilis, and disability-adj

158 abnormal renal arterial tree patterning and neonatal death consistent with kidney dysfunction.

159 cent achievements to reduce child mortality, neonatal deaths continue to remain high, accounting for

160 lowest HDI, 61% of all maternal, fetal, and neonatal deaths could be prevented.

161 Gestational age is the major determinant of neonatal death (death within the first 28 days of life)

162 Mice that escape neonatal death develop abnormal chemoresponsiveness as a

163 rence 0.3%, 95% CI -0.8 to 1.5; p=0.566) and neonatal deaths did not differ significantly between gro

164 ratory system, loss of Hoxa5 function causes neonatal death due to respiratory distress.

165 births become more common, the proportion of neonatal deaths due to hospital-onset sepsis has increas

166 The estimated number of neonatal deaths during the same period decreased from 5.

167 The early neonatal death (ENND) rate declined 12% between 1996 and

168 However, the relative risk of neonatal death following a preeclamptic pregnancy has no

169 t for children and a possible higher risk of neonatal death following the introduction of a multiface

170 icant reduction from baseline in the rate of neonatal death from all causes in the 7 days after birth

171 on is about double the risk of stillbirth or neonatal death from intrapartum uterine rupture.

172 topsy studies representing more than 100 000 neonatal deaths globally and 16 962 deaths among childre

173 As an estimated 23% of neonatal deaths globally are due to infectious causes, m

174 up to 15% of an estimated 3.3 million annual neonatal deaths globally.

175 Three-quarters of neonatal deaths happen in the first week--the highest ri

176 d encourage reappraisal of care during which neonatal death has occurred.

177 rs a 100 g periviable live birth infant as a neonatal death has placed Ohio and the United States at

178 Although almost half of all neonatal deaths identified met minimum IDS criteria, mos

179 ated the absolute reductions in maternal and neonatal deaths if countries with low CDR increased thei

180 ience a considerably increased likelihood of neonatal death in East Africa.

181 ous substances on Earth and a major cause of neonatal death in nonvaccinated areas.

182 y affecting skeletal muscles that results in neonatal death in severe cases as a result of associated

183 hether maternal obesity is a risk factor for neonatal death in sub-Saharan Africa and the effect on t

184 The rate of neonatal death in the 7 days after birth did not decreas

185 ters, there was no reduction in the rates of neonatal death in the 7 days after birth, stillbirth, or

186 The primary outcome was neonatal death in the first 7 days after birth.

187 ge, termination of pregnancy, stillbirth, or neonatal death in the metformin group (n=7) versus the p

188 changes affecting the risk of stillbirth and neonatal death in the offspring of men exposed to gonada

189 We calculated maternal and neonatal deaths in 2013 and 2012, respectively, for coun

190 uced litter size, and increased incidence of neonatal deaths in offspring.

191 The primary outcomes were stillbirths and neonatal deaths in the 5 years before the survey intervi

192 There were 230 neonatal deaths in the Newhints zones compared with 252

193 le logistic regression to assess the risk of neonatal death (in women's most recent singleton livebir

194 e or underlying CoD in 57.5% (n = 88) of all neonatal deaths, including the immediate CoD in 70.4% (5

195 We excluded stillbirths and neonatal deaths, infants whose mothers died, those with

196 stational age and Apgar score on the risk of neonatal death is unknown.

197 The risk of early neonatal death is very high across a range of countries

198 nding the causes and factors contributing to neonatal deaths is needed to identify interventions that

199 Early success in averting neonatal deaths is possible in settings with high mortal

200 The maximum effect on neonatal deaths is through interventions delivered durin

201 ch early initiation of breastfeeding reduces neonatal deaths is unclear, although the most likely pat

202 Secondary outcomes were neonatal death, large for gestational age, macrosomia, i

203 cy increases the incidence of stillbirth and neonatal death, leads to structural defects in the place

204 Enzyme replacement prevents neonatal death, liver damage, and osteoporosis in murine

205 cy were prospectively related to fetal loss, neonatal death, low birth weight, preterm birth, and MTC

206 life-years (DALYs) arising from stillbirths, neonatal death, low birthweight, mild and moderate mater

207 djusted life-years (DALYs) for fetal loss or neonatal death, low birthweight, moderate or severe mate

208 percentile of weight for gestational age) or neonatal death (<28 days from delivery), and any severe

209 here were no stillbirths and fewer than five neonatal deaths (<2.7%) in affected pregnancies compared

210 No study reported neonatal deaths, maternal morbidity, preterm births, or

211 nsent (2%), a test was not done due to early neonatal death (n=13), mother departing before venesecti

212 (both in the Foley catheter group) and eight neonatal deaths (n=5 in the misoprostol group and n=3 in

213 ed ovum, n=1; intrauterine death, n=2; early neonatal death, n=1; and neonatal death, n=2).

214 e death, n=2; early neonatal death, n=1; and neonatal death, n=2).

215 ers is essential to achieve the reduction in neonatal deaths needed to meet the Millennium Developmen

216 range of adverse outcomes including fetal or neonatal death, neurodisability, and lifelong risks to t

217 (PTD), small for gestational age (SGA), and neonatal death (NND).

218 Neonatal deaths now account for 47% of all deaths in chi

219 An estimated 5.1 million stillbirths and neonatal deaths occur annually.

220 of pregnancies; fetal death occurred in 4%, neonatal death occurred in 1%, preterm delivery occurred

221 Neonatal death occurred in 278 of 1417 infants (19.6%) i

222 Stillbirth or neonatal death occurred in 393 of 1532 fetuses and infan

223 One neonatal death occurred.

224 Stillbirths and neonatal deaths occurred among 7 MRI-exposed vs 9844 une

225 l and 1 117 257 (95% CI 1 033 611-1 200 902) neonatal deaths occurred in 45 countries with low CDRs i

226 52% of 87 neonatal deaths occurred in preterm or small for gestati

227 1.00 million (36.3%) of all neonatal deaths occurred on day 0 (uncertainty range 0.9

228 n exposed to this strategy, an excess of 3.5 neonatal deaths occurred, and the risk of maternal infec

229 12 fetuses (2%) died in utero and 27 (6%) neonatal deaths occurred.

230 al obesity was a significant risk factor for neonatal deaths occurring during the first 2 days of lif

231 s <1 month of age, with approximately 86% of neonatal deaths occurring in low- and lower-middle-incom

232 ound metabolic disorder that resulted in the neonatal deaths of numerous siblings.

233 in enlargement, hyperactivation of mTOR, and neonatal death on P0 due to reduced pup-maternal interac

234 .21, 0.77; P = 0.005) but was also shown for neonatal deaths on days 1-30 of life (aHR: 0.69; 95% CI:

235 rm, small-for-gestational age), birthweight, neonatal death or LAZ.

236 ly decrease or increase the risk of fetal or neonatal death or serious neonatal morbidity, as compare

237 primary outcome was a composite of fetal or neonatal death or serious neonatal morbidity, with the f

238 primary outcome was a composite of fetal or neonatal death or the need for placement of a cerebrospi

239 erinatal outcome (either maternal, fetal, or neonatal death, or severe morbidity for the mother or ba

240 desh, neonatal sepsis is the cause of 24% of neonatal deaths, over 65% of which occur in the early-ne

241 ere subfertile with small litters and higher neonatal death (P < 0.02).

242 onatal mortality (i.e., the excess number of neonatal deaths per 100 births) according to the Apgar s

243 ficantly lower in the intervention arm (21.3 neonatal deaths per 1000 live births vs 30.1 per 1000 in

244 elated inequality increased by more than 1.5 neonatal deaths per 1000 livebirths per year in Ethiopia

245 th distribution was reduced by more than two neonatal deaths per 1000 livebirths per year.

246 s per 1000 total births, and no more than 10 neonatal deaths per 1000 livebirths, compatible with the

247 eaths per 1000 pregnancies and 2.4 (0.7-4.1) neonatal deaths per 1000 livebirths.

248 eaths per 1000 pregnancies and 2.3 (0.9-3.7) neonatal deaths per 1000 livebirths.

249 0,396 deaths) to estimate the proportions of neonatal deaths per day and used bootstrap sampling to d

250 atios for combined mortality (fetal loss and neonatal death) per unit increase in the natural log of

251 reterm birth complications (187 [42%] of 449 neonatal deaths), perinatal asphyxia or hypoxia (98 [22%

252 Neonatal death, preterm birth, and pregnancy loss occurr

253 ficient for rescuing Insr knockout mice from neonatal death, preventing diabetes ketoacidosis, and no

254 rescues insulin receptor knockout mice from neonatal death, prevents diabetes in a majority of anima

255 The incidence of neonatal death ranged from 0.2% (at 36 weeks of gestatio

256 Consequently, a higher neonatal death rate (57.1%) in hUGT1/Tlr2(-/-) mice was

257 762-163 513 and 279 584-803 129 maternal and neonatal deaths, respectively.

258 chanical ventilation >/=24 h, stillbirth, or neonatal death); respiratory distress syndrome; any mech

259 gestational age, stillbirth, birth defects, neonatal death), results were mixed and depended on the

260 ions, stillbirths, congenital anomalies, and neonatal death (serious adverse events), as well as mate

261 s the rate of a composite primary outcome of neonatal death, severe intraventricular haemorrhage (IVH

262 National aims to reduce neonatal deaths should be set, and interventions incorpo

263 interval (CI): 1.38, 1.54 (n = 57 studies)), neonatal death (sRR = 1.22, 95% CI: 1.14, 1.30 (n = 28))

264 ks of neonatal death alone and stillbirth or neonatal death than the use of placebo, without an incre

265 ristics associated with an increased risk of neonatal death, the rate was lower in the regions with 4

266 In 2010, due to a pertussis outbreak and neonatal deaths, the California Department of Health rec

267 goal of reducing the numbers of maternal and neonatal deaths, the Government of India launched Janani

268 ficantly increased the risk of stillbirth or neonatal death (three [4%] of 69, 4.7 [1.2-19.0]).

269 erity of renal disease, which can range from neonatal death to adequate function into old age, charac

270 ords were also extracted for stillbirths and neonatal deaths, to incorporate reported pregnancy or de

271 Adverse events included neonatal death (two in the standard care group and three

272 death, defined as intrapartum stillbirth or neonatal death unrelated to congenital anomaly, compared

273 ero fetal death after randomisation or known neonatal death up to 7 days after birth), preterm delive

274 d related these to the risk of stillbirth or neonatal death using Poisson regression analysis.

275 The risk of stillbirth or neonatal death was 1.7% versus 0.7% (odds ratio, 2.39; 9

276 The odds ratio for neonatal death was 2.81 (95% CI: 0.73, 10.8).

277 The rate of neonatal death was similar between groups (2.54 vs 2.21

278 adiation and malformations, stillbirths, and neonatal deaths was not seen in the children of female s

279 The corresponding ORs for neonatal death were 0.89 (95% CI, 0.58-1.39; P = .62) fo

280 tion; neonatal death alone and stillbirth or neonatal death were evaluated with superiority analyses,

281 The most common underlying causes of neonatal death were preterm birth complications (187 [42

282 After birth 16 perinatal or early neonatal deaths were encountered and five lost to follow

283 hs, 5,470 cases of low birth weight, and 430 neonatal deaths were prevented.

284 482 neonatal deaths were recorded.

285 Combined fetal loss and neonatal deaths were reduced by 11% (RR 0.89, 0.81-1.00,

286 mutations resulted in severe phenotypes with neonatal death, whereas missense changes resulted in imp

287 and palate (one), microtia alone (one), and neonatal death with multiple malformations (one).

288 Among neonatal deaths with underlying prematurity, 60% were pr

289 Sepsis is the third most common cause of neonatal death, with Group B Streptococcus (GBS) being t

290 weeks' gestation, are at the highest risk of neonatal death, with ongoing post-neonatal mortality ris

291 s that generated funds for transport reduced neonatal deaths, with the largest effect seen in India (

292 ster MRI exposure, the risk of stillbirth or neonatal death within 28 days of birth and any congenita

293 an section, Apgar score <7 at 5 minutes, and neonatal death within 28 days.

294 or mechanical ventilation) or stillbirth or neonatal death within 72 hours after delivery.

295 Preterm birth (PTB) is a leading cause of neonatal death worldwide.

296 The 2.9 million annual neonatal deaths worldwide are attributable to three main

297 While information about 4 million neonatal deaths worldwide is limited, even less informat

298 infections remain one of the main causes of neonatal deaths worldwide.

299 rventions could avert an estimated 41-72% of neonatal deaths worldwide.

300 bor and infections are the leading causes of neonatal deaths worldwide.